MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma—A step towards personalized therapy

Clinical Epigenetics

Volumn 7, Issue 1, 2015, Pages

  Garajová, Ingrid ^a,b   Funel, Niccola ^c,d   Fiorentino, Michelangelo ^b   Agostini, Valentina ^b   Ferracin, Manuela ^e   Negrini, Massimo ^e   Frassineti, Giovanni Luca ^f   Gavelli, Giampaolo ^f   Frampton, Adam Enver ^g   Biasco, Guido ^b   Giovannetti, Elisa ^a,d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY OF FERRARA   (Italy)

^f DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^g HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Enteric; Immunohistochemistry; Intestinal; PEAC; Pulmonary adenocarcinoma

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; BISPHOSPHONIC ACID DERIVATIVE; CAPECITABINE; CARBOPLATIN; CYTOKERATIN 20; CYTOKERATIN 7; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE F 18; FORMALDEHYDE; MICRORNA; MICRORNA 126; MICRORNA 31; MICRORNA 506; MICRORNA 508 3P; MICRORNA 514; MUCIN 1; MUCIN 2; MUCIN 5AC; MUCIN 6; NAPSIN A; ONCOPROTEIN; OXALIPLATIN; PARAFFIN; PEMETREXED; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG;

ADRENAL METASTASIS; AGE; AGED; ALK GENE; ARTICLE; BONE METASTASIS; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EGFR GENE; FEMALE; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; NON SMALL CELL LUNG CANCER; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PERSONALIZED MEDICINE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIMARY PULMONARY ENTERIC ADENOCARCINOMA; PRIORITY JOURNAL; PROBABILITY; SMOKING HABIT; TUMOR LOCALIZATION;

EID: 84949843568     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/s13148-015-0162-5     Document Type: Article

References (24)

1. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. American Thoracic Society. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244-85.
2. Tsao MS, Fraser RS. Primary pulmonary adenocarcinoma with enteric differentiation. Cancer. 1991;68(8):1754-7.
3. Inamura K, Satoh Y, Okumura S, Nakagawa K, Tsuchiya E, Fukayama M, et al. Pulmonary adenocarcinomas with entric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas. Am J Surg Pathol. 2005;29(5):660-5.
4. Maeda R, Isowa N, Onuma H, Miura H. Pulmonary intestinal-type adenocarcinoma. Interact Cardiovasc Thorac Surg. 2008;7(2):349-51.
5. Li HC, Schmidt L, Greenson JK, Chang AC, Myers JL. Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature. Am J Clin Pathol. 2009;13(1):129-33.
6. Hatanaka K, Tsuta K, Watanabe K, Sugino K, Uekusa T. Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: a report of the second case negative for cytokeratin 7. Pathol Res Pract. 2011;207(3):188-91.
7. Lin D, Zhao Y, Li H, Xing X. Pulmonary enteric adenocarcinoma with villin brush border immunoreactivity: a case report and literature review. J Thorac Dis. 2013;5(1):E17-20.
8. Qureshi A, Furrukh M. Enteric adenocarcinoma lung: a rare presentation in an Omani woman. BMJ Case Rep 2013
9. László T, Lacza A, Tóth D, Molnár TF, Kálmán E. Pulmonary enteric adenocarcinoma indistinguishable from metastatic colorectal carcinoma morphologically and immunohistologically. Histopathology. 2014;65(2):283-7.
10. Wang CX, Liu B, Wang YF, Zhang RS, Yu B, Lu ZF, et al. Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases. Int J Clin Exp Pathol. 2014;7(3):1266-74.
11. Stojsic J, Kontic M, Subotic D, Popovic M, Tomasevic D, Lukic J. Intestinal type of lung adenocarcinoma in younger adults. Case Rep Pulmonol. 2014;2014:282196.
12. Yousem SA. Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study. Mod Pathol. 2005;18(6):816-21.
13. El Hammoumi MM, El Ochi R, Kabiri EH. Primary lung adenocarcinoma with enteric morphology associated with primary colon adenocarcinoma. Arch Bronconeumol, 2015 [Epub ahead of print].
14. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26(4):462-9.
15. Ferracin M, Pedriali M, Veronese A, Zagatti B, Gafà R, Magri E, et al. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin. J Pathol. 2011;225(1):43-53.
16. Park C, Lee IJ, Jang SH, Lee JW. Factors affecting tumor recurrence after curative surgery for NSCLC: impacts of lymphovascular invasion on early tumor recurrence. J Thorac Dis. 2014;6(10):1420-8.
17. Permuth-Wey J, Chen YA, Fisher K, McCarthy S, Qu X, Lloyd MC, et al. A genome-wide investigation of microRNA expression identifies biologicallymeaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas. PLoS One. 2015;10(1):e0116869.
18. Frampton AE, Krell J, Jacob J, Stebbing J, Castellano L, Jiao LR. Loss of miR-126 is crucial to pancreatic cancer progression. Expert Rev Anticancer Ther. 2012;12(7):881-4.
19. Yin M, Ren X, Zhang X, Luo Y, Wang G, Huang K, et al. Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation. Oncogene. 2014. doi:10.1038/onc.2013.597.
20. Sun Y, Hu L, Zheng H, Bagnoli M, Guo Y, Rupaimoole R, et al. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer. J Pathol. 2015;235(1):25-36.
21. Zhai Q, Zhou L, Zhao C, Wan J, Yu Z, Guo X, et al. Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma. Biochem Biophys Res Commun. 2012;419(4):621-6.
22. Garajová I, Le Large TY, Frampton AE, Rolfo C, Voortman J, Giovannetti E. Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer. Biomed Res Int. 2014;2014:678401.
23. Frampton AE, Giovannetti E, Jamieson NB, Krell J, Gall TM, Stebbing J, et al. A microRNA meta-signature for pancreatic ductal adenocarcinoma. Expert Rev Mol Diagn. 2014;14(3):267-71.
24. Castellano-Megias VM, Ibarrola-de Andres C, Lopez-Alfonso G, Colina-Ruizdelgado F. Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas. World J Gastrointest Oncol. 2014;6(9):311-24.